BRIEF published on 09/18/2024 at 20:05, 1 year 7 months ago Levée de fonds de 0,25 M€ par Néovacs Investissement Biotechnologie Levée De Fonds Dilution OCEANE-BSA
PRESS RELEASE published on 09/18/2024 at 20:00, 1 year 7 months ago Levée de fonds de 0,25 MEUR Néovacs annonce une levée de fonds de 0,25 M€ via l'émission d'OCEANE-BSA pour financer la recherche sur les allergies et investir dans des projets prometteurs en Biotech et MedTech Biotech Levée De Fonds Néovacs OCEANE-BSA Recherche Allergies
BRIEF published on 08/28/2024 at 23:05, 1 year 8 months ago Adjustment of the nominal value: Neovacs reduces its capital Financial Health Euronext Growth Capital Reduction Nominal Value Néovacs
BRIEF published on 08/28/2024 at 23:05, 1 year 8 months ago Ajustement de la valeur nominale : Néovacs réduit son capital Euronext Growth Réduction De Capital Santé Financière Valeur Nominale Néovacs
PRESS RELEASE published on 08/28/2024 at 23:00, 1 year 8 months ago Ajustement de la valeur nominale Néovacs réduit la valeur nominale de son action de 0,005 € à 0,0005 € suite à une réduction de capital. La société biopharmaceutique développe des thérapies pour des maladies inflammatoires et auto-immunes Biopharmaceutique Réduction De Capital Maladies Inflammatoires Valeur Nominale Néovacs
BRIEF published on 07/04/2024 at 20:05, 1 year 10 months ago Termination of the financing contract granted to Pharnext Termination Funding Biopharmaceutical Pharnext Néovacs
BRIEF published on 07/04/2024 at 20:05, 1 year 10 months ago Résiliation du contrat de financement accordé à Pharnext Financement Biopharmaceutique Pharnext Résiliation Néovacs
PRESS RELEASE published on 07/04/2024 at 20:00, 1 year 10 months ago Résiliation du contrat de financement accordé à Pharnext Résiliation du contrat de financement entre Néovacs et Pharnext, suite à des cas de défaut. Le fiduciaire demande le remboursement anticipé de 22 M€. Détails sur les sûretés en place Financement Pharnext Résiliation Néovacs Fiduciaire
BRIEF published on 06/17/2024 at 08:05, 1 year 10 months ago Néovacs collaborates with the CNRS to develop mRNA lipid formulations Scientific Collaboration Biomedical Research Néovacs CNRS Lipid Formulations Messenger RNA
BRIEF published on 06/17/2024 at 08:05, 1 year 10 months ago Néovacs collabore avec le CNRS pour développer des formulations lipidiques ARNm Collaboration Scientifique Recherche Biomédicale Formulations Lipidiques ARN Messager Néovacs CNRS
Published on 05/11/2026 at 19:55, 2 hours 13 minutes ago Lithium South Announces Pay Out of Common Shares and Closing of Plan of Arrangement
Published on 05/11/2026 at 19:30, 2 hours 38 minutes ago Taranis Adjusts Thor Exploration Program Due to Current Political and Regulatory Conditions in British Columbia
Published on 05/11/2026 at 14:30, 7 hours 38 minutes ago Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides
Published on 05/11/2026 at 14:00, 8 hours 8 minutes ago Unusual Machines Accelerates Domestic Battery Manufacturing by Signing a Merger Agreement to Acquire Upgrade Energy
Published on 05/11/2026 at 14:00, 8 hours 8 minutes ago New Horizon Aircraft Ltd. Announces Closing of $20 Million Offering of Common Shares
Published on 05/11/2026 at 21:16, 51 minutes ago Original-Research: Intershop Communications (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 05/11/2026 at 20:42, 1 hour 25 minutes ago Grand City Properties S.A. proposes Dividend Payment combined with Dividend Policy Update
Published on 05/11/2026 at 20:40, 1 hour 28 minutes ago EQS-Adhoc: Grand City Properties S.A. proposes Dividend Payment combined with Dividend Policy Update
Published on 05/11/2026 at 19:28, 2 hours 39 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/11/2026 at 19:17, 2 hours 51 minutes ago Position of Commerzbank on UniCredit’s offer
Published on 05/11/2026 at 19:02, 3 hours 5 minutes ago 260511 BENETEAU Transactions sur actions propres
Published on 05/11/2026 at 18:18, 3 hours 50 minutes ago Reporting on share buyback transactions carried out between May 4 and May 5, 2026
Published on 05/11/2026 at 18:18, 3 hours 50 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 4 et 5 mai 2026
Published on 05/11/2026 at 18:14, 3 hours 53 minutes ago Nombre total d'actions et droits de vote - avril 2026
Published on 05/11/2026 at 18:14, 3 hours 53 minutes ago Number of shares and voting rights - April 2026 (In French only)
